
You can purchase shares of NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc (OTCEM:NBRVF) through any online brokerage.
There are no as such competitors for NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc.
There is no analysis for NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc to provide a consensus price target.
The stock price for NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc (OTCEM: NBRVF) is $0.0003 last updated November 13, 2026 at 10:32 AM EST.
There are no upcoming dividends for NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc.
NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc does not have any upcoming earnings scheduled.
There is no upcoming split for NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc.
NABRIVA THERAPEUTICS NEW by Nabriva Therapeutics plc is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. The company is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The...